Edwards Lifesciences Corporation (BIT:1EW)

Italy flag Italy · Delayed Price · Currency is EUR
65.66
0.00 (0.00%)
At close: Jul 16, 2025, 5:30 PM CET
Market Cap38.22B
Revenue (ttm)5.11B
Net Income (ttm)3.87B
Shares Outn/a
EPS (ttm)6.50
PE Ratio9.88
Forward PE30.97
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume16
Open65.66
Previous Close65.66
Day's Range65.66 - 65.66
52-Week Range55.14 - 84.66
Betan/a
RSI53.64
Earnings DateJul 23, 2025

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1958
Employees 15,800
Stock Exchange Borsa Italiana
Ticker Symbol 1EW
Full Company Profile

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.